| 摘要 |
The invention provides compositions, polynucleotides and proteins that coexpress with known matrix-remodeling genes. The invention also provides expression vectors and host cells, and ligands and antibodies which specifically bind the proteins. The invention also relates to the use of these biomolecules in diagnosis, prognosis, prevention, treatment, and evaluation of therapies for diseases associated with matrix-remodeling. |
